Intravenous bisphosphonates
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
e20007Background: RI is prevalent in MM patients and associated with poor survival and increased costs. IVBPs are recommended to…
e20665 Background: Cancer patients with BMets are predisposed to skeletal complications. Bone targeted therapies such as…
192 Background: Bone is a common site of metastatic involvement in patients (pts) with prostate cancer (PC). Bony metastases…
For many solid tumors, bone is a common site of spread and one that compromises the quality of life of patients. The routine use…
e19619 Background: Metastatic bone disease is a common complication of several malignancies, including breast cancer, prostate…
1035 Background: Intravenous bisphosphonates (IV BPs) are safe and effective in reducing skeletal related events in MBC. The…
Background: Metastatic bone disease, a common complication of malignancy, causes significant morbidity in affected patients…
e22104 Background: Risk of acute renal failure (ARF) among breast cancer (BC) patients may increase with nephrotoxic chemotherapy…